Paul N. Mudd, Jr., PharmD, MBA

Research Reports

Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study

05/18/2021

Drishti Shah , PhD;

Jason Yeaw , MPH;

Amy Kincaid , MA;

Paul N. Mudd Jr., PharmD, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.

Richard Stefanacci, DO, and...

05/18/2021

Journal of Clinical Pathways

Practical Research

High Utilization of CYP2D6 Substrate Prescriptions Among Long-Term Care Residents With Overactive Bladder

10/07/2022

Jason Yeaw , MPH;

Adam Carrera , PharmD;

Paul N. Mudd Jr., PharmD, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

John R. Horn , PharmD;

Noelia Goti , BS;

Stacie Holland , PharmD;

Drishti Shah , PhD;

This study aims to describe the prevalence of CYP2D6 substrate use among LTC residents with OAB and among a subset of residents with OAB receiving mirabegron.

This study aims to describe the...

10/07/2022

Annals of Long-Term Care

Review

Urinary Incontinence and Use of Anticholinergics Independently Impact Quality Measure Area Performance in Nursing Homes: A Targeted Literature Review and Expert Panel Review

05/05/2023

Edith G. Walsh ;

Qinghua Li ;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Molly W. Vaughan ;

Mark Hatem ;

Paul N. Mudd Jr., PharmD, MBA;

This literature review and advisory panel discussions highlight the need to increase education regarding anticholinergic burden for managing UI and lessening the adverse health outcomes assessed by NHQI quality measures.

This literature review and...

05/05/2023

Annals of Long-Term Care